Kenvue readying defense if Tylenol is cited in RFK Jr’s autism report: WSJ

2 hours ago 1
Sealed Bottle of Extra Strength Tylenol Caplets with Box

skhoward/iStock Unreleased via Getty Images

Kenvue (NYSE:KVUE) is planning a strong defense if an upcoming report from the Health and Human Services Department links autism with acetaminophen, the active ingredient in its Tylenol pain medication, The Wall Street Journal reported on Friday.

The company is

Recommended For You

More Trending News

Read Entire Article